
Learn how patient quality of life (QoL) data is quantified into Quality-Adjusted Life Years (QALYs) to perform cost-effectiveness analysis for specialty drugs.

Learn how patient quality of life (QoL) data is quantified into Quality-Adjusted Life Years (QALYs) to perform cost-effectiveness analysis for specialty drugs.

Updated 2026 guide to US mail-order specialty pharmacies. Covers $751B market, top players (CVS, Optum, Express Scripts), FTC PBM reform, Walgreens-Sycamore split, GLP-1 growth, and specialty drug distribution trends.

Learn the key differences between pharmacy vs. medical benefit and how this structure impacts insurance coverage for GLP-1 drugs for diabetes and obesity, including the 2025–2026 Medicare BALANCE Model, manufacturer price cuts, and employer coverage trends.

An in-depth analysis of the specialty pharmacy industry covering key players (PBMs, distributors), market trends, biosimilar competition, PBM reform, and the economics of high-cost specialty drugs. Updated March 2026.
© 2026 IntuitionLabs. All rights reserved.